Pharma exports up 3 pc to $17.3 billion in 2017-18

Import alerts by the US Food and Drug Administration, regulatory hurdles and currency fluctuation also contributed to slow growth in the overseas shipments, an industry expert said.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2MfvPoH
via IFTTT